Press release
Biological API Drug Manufacturing Market by Manufacturers: Lonza, Boehringer Ingelheim BioXcellence, Celltrion, DSM, Samsung BioLogics
Biological API Drug Manufacturing Market research report provides an overview of the competitive landscape among the leading manufacturers in the world, including sales, revenue, and market share. In addition, it analyzes the central regions by manufacturers, categories, and applications, covering such areas as North America, Europe, Asia Pacific, the Middle East, and South America, with sales, revenue, and market share segmented by manufacturer types and applications.Request a Free PDF Sample of the Report: https://www.reportsnreports.com/contacts/requestsample.aspx?name=5897829
The research report includes specific segments by region (country), by manufacturers, by Type and by Application. Each type provides information about the production during the forecast period of 2017 to 2028. by Application segment also provides consumption during the forecast period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
- In-House manufacturing
- Contract manufacturing
Segment by Application
- Monoclonal Antibody (mAb) Therapies
- Vaccines
- Insulin Therapies
- Interferon Therapies
- Other
By Company
- Lonza
- Boehringer Ingelheim BioXcellence
- Celltrion
- DSM
- Samsung BioLogics
- Fujifilm Diosynth Biotechnologies
- Cytovance Biologics
- AbbVie
- Baxter
- CEPiA Sanofi
- GSK
- Pfizer CentreOne
- Sandoz
- Vetter
- Wuxi Biologics
Production by Region
- North America
- Europe
- China
- Japan
Consumption by Region
- North America
- - U.S.
- - Canada
- Europe
- - Germany
- - France
- - U.K.
- - Italy
- - Russia
- Asia-Pacific
- - China
- - Japan
- - South Korea
- - India
- - Australia
- - Taiwan
- - Indonesia
- - Thailand
- - Malaysia
- - Philippines
- - Vietnam
- Latin America
- - Mexico
- - Brazil
- - Argentina
Purchase This Report: https://www.reportsnreports.com/purchase.aspx?name=5897829
Table of Contents
1 Biological API Drug Manufacturing Market Overview
1.1 Product Overview and Scope of Biological API Drug Manufacturing
1.2 Biological API Drug Manufacturing Segment by Type
1.2.1 Global Biological API Drug Manufacturing Market Size Growth Rate Analysis by Type 2022 VS 2028
1.2.2 In-House manufacturing
1.2.3 Contract manufacturing
1.3 Biological API Drug Manufacturing Segment by Application
1.3.1 Global Biological API Drug Manufacturing Consumption Comparison by Application: 2022 VS 2028
1.3.2 Monoclonal Antibody (mAb) Therapies
1.3.3 Vaccines
1.3.4 Insulin Therapies
1.3.5 Interferon Therapies
1.3.6 Other
1.4 Global Market Growth Prospects
1.4.1 Global Biological API Drug Manufacturing Revenue Estimates and Forecasts (2017-2028)
1.4.2 Global Biological API Drug Manufacturing Production Capacity Estimates and Forecasts (2017-2028)
1.4.3 Global Biological API Drug Manufacturing Production Estimates and Forecasts (2017-2028)
1.5 Global Market Size by Region
1.5.1 Global Biological API Drug Manufacturing Market Size Estimates and Forecasts by Region: 2017 VS 2021 VS 2028
1.5.2 North America Biological API Drug Manufacturing Estimates and Forecasts (2017-2028)
1.5.3 Europe Biological API Drug Manufacturing Estimates and Forecasts (2017-2028)
1.5.4 China Biological API Drug Manufacturing Estimates and Forecasts (2017-2028)
1.5.5 Japan Biological API Drug Manufacturing Estimates and Forecasts (2017-2028)
2 Market Competition by Manufacturers
2.1 Global Biological API Drug Manufacturing Production Capacity Market Share by Manufacturers (2017-2022)
2.2 Global Biological API Drug Manufacturing Revenue Market Share by Manufacturers (2017-2022)
2.3 Biological API Drug Manufacturing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.4 Global Biological API Drug Manufacturing Average Price by Manufacturers (2017-2022)
2.5 Manufacturers Biological API Drug Manufacturing Production Sites, Area Served, Product Types
2.6 Biological API Drug Manufacturing Market Competitive Situation and Trends
2.6.1 Biological API Drug Manufacturing Market Concentration Rate
2.6.2 Global 5 and 10 Largest Biological API Drug Manufacturing Players Market Share by Revenue
2.6.3 Mergers & Acquisitions, Expansion
3 Production Capacity by Region
3.1 Global Production Capacity of Biological API Drug Manufacturing Market Share by Region (2017-2022)
3.2 Global Biological API Drug Manufacturing Revenue Market Share by Region (2017-2022)
3.3 Global Biological API Drug Manufacturing Production Capacity, Revenue, Price and Gross Margin (2017-2022)
3.4 North America Biological API Drug Manufacturing Production
3.4.1 North America Biological API Drug Manufacturing Production Growth Rate (2017-2022)
3.4.2 North America Biological API Drug Manufacturing Production Capacity, Revenue, Price and Gross Margin (2017-2022)
3.5 Europe Biological API Drug Manufacturing Production
3.5.1 Europe Biological API Drug Manufacturing Production Growth Rate (2017-2022)
3.5.2 Europe Biological API Drug Manufacturing Production Capacity, Revenue, Price and Gross Margin (2017-2022)
3.6 China Biological API Drug Manufacturing Production
3.6.1 China Biological API Drug Manufacturing Production Growth Rate (2017-2022)
3.6.2 China Biological API Drug Manufacturing Production Capacity, Revenue, Price and Gross Margin (2017-2022)
3.7 Japan Biological API Drug Manufacturing Production
3.7.1 Japan Biological API Drug Manufacturing Production Growth Rate (2017-2022)
3.7.2 Japan Biological API Drug Manufacturing Production Capacity, Revenue, Price and Gross Margin (2017-2022)
4 Global Biological API Drug Manufacturing Consumption by Region
4.1 Global Biological API Drug Manufacturing Consumption by Region
4.1.1 Global Biological API Drug Manufacturing Consumption by Region
4.1.2 Global Biological API Drug Manufacturing Consumption Market Share by Region
4.2 North America
4.2.1 North America Biological API Drug Manufacturing Consumption by Country
4.2.2 U.S.
4.2.3 Canada
4.3 Europe
4.3.1 Europe Biological API Drug Manufacturing Consumption by Country
4.3.2 Germany
4.3.3 France
4.3.4 U.K.
4.3.5 Italy
4.3.6 Russia
4.4 Asia Pacific
4.4.1 Asia Pacific Biological API Drug Manufacturing Consumption by Region
4.4.2 China
4.4.3 Japan
4.4.4 South Korea
4.4.5 China Taiwan
4.4.6 Southeast Asia
4.4.7 India
4.4.8 Australia
4.5 Latin America
4.5.1 Latin America Biological API Drug Manufacturing Consumption by Country
4.5.2 Mexico
4.5.3 Brazil
5 Segment by Type
5.1 Global Biological API Drug Manufacturing Production Market Share by Type (2017-2022)
5.2 Global Biological API Drug Manufacturing Revenue Market Share by Type (2017-2022)
5.3 Global Biological API Drug Manufacturing Price by Type (2017-2022)
6 Segment by Application
6.1 Global Biological API Drug Manufacturing Production Market Share by Application (2017-2022)
6.2 Global Biological API Drug Manufacturing Revenue Market Share by Application (2017-2022)
6.3 Global Biological API Drug Manufacturing Price by Application (2017-2022)
7 Key Companies Profiled
7.1 Lonza
7.1.1 Lonza Biological API Drug Manufacturing Corporation Information
7.1.2 Lonza Biological API Drug Manufacturing Product Portfolio
7.1.3 Lonza Biological API Drug Manufacturing Production Capacity, Revenue, Price and Gross Margin (2017-2022)
7.1.4 Lonza Main Business and Markets Served
7.1.5 Lonza Recent Developments/Updates
7.2 Boehringer Ingelheim BioXcellence
7.2.1 Boehringer Ingelheim BioXcellence Biological API Drug Manufacturing Corporation Information
7.2.2 Boehringer Ingelheim BioXcellence Biological API Drug Manufacturing Product Portfolio
7.2.3 Boehringer Ingelheim BioXcellence Biological API Drug Manufacturing Production Capacity, Revenue, Price and Gross Margin (2017-2022)
7.2.4 Boehringer Ingelheim BioXcellence Main Business and Markets Served
7.2.5 Boehringer Ingelheim BioXcellence Recent Developments/Updates
7.3 Celltrion
7.3.1 Celltrion Biological API Drug Manufacturing Corporation Information
7.3.2 Celltrion Biological API Drug Manufacturing Product Portfolio
7.3.3 Celltrion Biological API Drug Manufacturing Production Capacity, Revenue, Price and Gross Margin (2017-2022)
7.3.4 Celltrion Main Business and Markets Served
7.3.5 Celltrion Recent Developments/Updates
7.4 DSM
7.4.1 DSM Biological API Drug Manufacturing Corporation Information
7.4.2 DSM Biological API Drug Manufacturing Product Portfolio
7.4.3 DSM Biological API Drug Manufacturing Production Capacity, Revenue, Price and Gross Margin (2017-2022)
7.4.4 DSM Main Business and Markets Served
7.4.5 DSM Recent Developments/Updates
7.5 Samsung BioLogics
7.5.1 Samsung BioLogics Biological API Drug Manufacturing Corporation Information
7.5.2 Samsung BioLogics Biological API Drug Manufacturing Product Portfolio
7.5.3 Samsung BioLogics Biological API Drug Manufacturing Production Capacity, Revenue, Price and Gross Margin (2017-2022)
7.5.4 Samsung BioLogics Main Business and Markets Served
7.5.5 Samsung BioLogics Recent Developments/Updates
7.6 Fujifilm Diosynth Biotechnologies
7.6.1 Fujifilm Diosynth Biotechnologies Biological API Drug Manufacturing Corporation Information
7.6.2 Fujifilm Diosynth Biotechnologies Biological API Drug Manufacturing Product Portfolio
7.6.3 Fujifilm Diosynth Biotechnologies Biological API Drug Manufacturing Production Capacity, Revenue, Price and Gross Margin (2017-2022)
7.6.4 Fujifilm Diosynth Biotechnologies Main Business and Markets Served
7.6.5 Fujifilm Diosynth Biotechnologies Recent Developments/Updates
7.7 Cytovance Biologics
7.7.1 Cytovance Biologics Biological API Drug Manufacturing Corporation Information
7.7.2 Cytovance Biologics Biological API Drug Manufacturing Product Portfolio
7.7.3 Cytovance Biologics Biological API Drug Manufacturing Production Capacity, Revenue, Price and Gross Margin (2017-2022)
7.7.4 Cytovance Biologics Main Business and Markets Served
7.7.5 Cytovance Biologics Recent Developments/Updates
7.8 AbbVie
7.8.1 AbbVie Biological API Drug Manufacturing Corporation Information
7.8.2 AbbVie Biological API Drug Manufacturing Product Portfolio
7.8.3 AbbVie Biological API Drug Manufacturing Production Capacity, Revenue, Price and Gross Margin (2017-2022)
7.8.4 AbbVie Main Business and Markets Served
7.7.5 AbbVie Recent Developments/Updates
7.9 Baxter
7.9.1 Baxter Biological API Drug Manufacturing Corporation Information
7.9.2 Baxter Biological API Drug Manufacturing Product Portfolio
7.9.3 Baxter Biological API Drug Manufacturing Production Capacity, Revenue, Price and Gross Margin (2017-2022)
7.9.4 Baxter Main Business and Markets Served
7.9.5 Baxter Recent Developments/Updates
7.10 CEPiA Sanofi
7.10.1 CEPiA Sanofi Biological API Drug Manufacturing Corporation Information
7.10.2 CEPiA Sanofi Biological API Drug Manufacturing Product Portfolio
7.10.3 CEPiA Sanofi Biological API Drug Manufacturing Production Capacity, Revenue, Price and Gross Margin (2017-2022)
7.10.4 CEPiA Sanofi Main Business and Markets Served
7.10.5 CEPiA Sanofi Recent Developments/Updates
7.11 GSK
7.11.1 GSK Biological API Drug Manufacturing Corporation Information
7.11.2 GSK Biological API Drug Manufacturing Product Portfolio
7.11.3 GSK Biological API Drug Manufacturing Production Capacity, Revenue, Price and Gross Margin (2017-2022)
7.11.4 GSK Main Business and Markets Served
7.11.5 GSK Recent Developments/Updates
7.12 Pfizer CentreOne
7.12.1 Pfizer CentreOne Biological API Drug Manufacturing Corporation Information
7.12.2 Pfizer CentreOne Biological API Drug Manufacturing Product Portfolio
7.12.3 Pfizer CentreOne Biological API Drug Manufacturing Production Capacity, Revenue, Price and Gross Margin (2017-2022)
7.12.4 Pfizer CentreOne Main Business and Markets Served
7.12.5 Pfizer CentreOne Recent Developments/Updates
7.13 Sandoz
7.13.1 Sandoz Biological API Drug Manufacturing Corporation Information
7.13.2 Sandoz Biological API Drug Manufacturing Product Portfolio
7.13.3 Sandoz Biological API Drug Manufacturing Production Capacity, Revenue, Price and Gross Margin (2017-2022)
7.13.4 Sandoz Main Business and Markets Served
7.13.5 Sandoz Recent Developments/Updates
7.14 Vetter
7.14.1 Vetter Biological API Drug Manufacturing Corporation Information
7.14.2 Vetter Biological API Drug Manufacturing Product Portfolio
7.14.3 Vetter Biological API Drug Manufacturing Production Capacity, Revenue, Price and Gross Margin (2017-2022)
7.14.4 Vetter Main Business and Markets Served
7.14.5 Vetter Recent Developments/Updates
7.15 Wuxi Biologics
7.15.1 Wuxi Biologics Biological API Drug Manufacturing Corporation Information
7.15.2 Wuxi Biologics Biological API Drug Manufacturing Product Portfolio
7.15.3 Wuxi Biologics Biological API Drug Manufacturing Production Capacity, Revenue, Price and Gross Margin (2017-2022)
7.15.4 Wuxi Biologics Main Business and Markets Served
7.15.5 Wuxi Biologics Recent Developments/Updates
8 Biological API Drug Manufacturing Manufacturing Cost Analysis
8.1 Biological API Drug Manufacturing Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Biological API Drug Manufacturing
8.4 Biological API Drug Manufacturing Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.2 Biological API Drug Manufacturing Distributors List
9.3 Biological API Drug Manufacturing Customers
10 Market Dynamics
10.1 Biological API Drug Manufacturing Industry Trends
10.2 Biological API Drug Manufacturing Market Drivers
10.3 Biological API Drug Manufacturing Market Challenges
10.4 Biological API Drug Manufacturing Market Restraints
11 Production and Supply Forecast
Contact Us:
Corporate Headquarters
Tower B5, office 101,
Magarpatta SEZ,
Hadapsar, Pune-411013, India
+ 1 888 391 5441
sales@reportsandreports.com
About Us:
ReportsnReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Biological API Drug Manufacturing Market by Manufacturers: Lonza, Boehringer Ingelheim BioXcellence, Celltrion, DSM, Samsung BioLogics here
News-ID: 2760726 • Views: …
More Releases from ReportsnReports
DeviceCon Series 2024 - UK Edition | MarketsandMarkets
Future Forward: Redefining Healthcare with Cutting-Edge Devices
Welcome to DeviceCon Series 2024 - Where Innovation Meets Impact!
Join us on March 21-22 at Millennium Gloucester Hotel, 4-18 Harrington Gardens, London SW7 4LH for a groundbreaking convergence of knowledge, ideas, and technology. MarketsandMarkets proudly presents the DeviceCon Series, an extraordinary blend of four conferences that promise to redefine the landscape of innovation in medical and diagnostic devices.
Register Now @ https://events.marketsandmarkets.com/devicecon-series-uk-edition-2024/register
MarketsandMarkets presents…
5th Annual MarketsandMarkets Infectious Disease and Molecular Diagnostics Confer …
London, March 7, 2024 - MarketsandMarkets is thrilled to announce the eagerly awaited 5th Annual Infectious Disease and Molecular Diagnostics Conference, scheduled to take place on March 21st - 22nd, 2024, at the prestigious Millennium Gloucester Hotel, located at 4-18 Harrington Gardens, London SW7 4LH.
This conference promises to be a groundbreaking event, showcasing the latest trends and insights in diagnosis, as well as unveiling cutting-edge technologies that are revolutionizing the…
Infection Control, Sterilization & Decontamination Conference |21st - 22nd March …
MarketsandMarkets is pleased to announce its 8th Annual Infection Control, Sterilisation, and Decontamination in Healthcare Conference, which will take place March 21-22, 2024, in London, UK. With the increased risk of infection due to improper sterilisation and decontamination practices, the safety of patients and healthcare workers is of paramount importance nowadays.
Enquire Now @ https://events.marketsandmarkets.com/infection-control-sterilization-and-decontamination-conference/
This conference aims to bring together all the stakeholders to discuss the obstacles in achieving…
Breast Augmentation Market Key Players, Demands, Cost, Size, Procedure, Shape, S …
The global Breast Augmentation Market in terms of revenue was estimated to be worth $900 million in 2020 and is poised to reach $1,692 million by 2025, growing at a CAGR of 13.4% from 2020 to 2025. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying…
More Releases for Manufacturing
Manufacturing the Future: Exploring the In-Space Manufacturing Market
Rapid improvements in space technology have created new opportunities for in-space production, transforming the space sector. The in-space manufacturing sector is expanding rapidly as space agencies and private companies investigate ways to manufacture products and structures in space. According to MarketsandMarkets' thorough market research analysis, the worldwide in-space manufacturing market is predicted to expand significantly in the next years. In this blog article, we will evaluate the recent trends and…
Global Miscellaneous Market by Types (Gasket, Packing, and Sealing Device Manufa …
The global Miscellaneous market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.
Global Miscellaneous Market overview
Miscellaneous Market research report offers great insights into the market and consumer data and their interpretation through various figures and graphs.
Miscellaneous markets have experienced significant growth in recent years. The main reason for this is the increasing…
Smart Factory Transforming from “Manufacturing” to “Intelligent Manufactur …
The concept of “Industry 4.0” was officially announced by the German government in 2013 at the Hannover Messe. Since then, its influence has taken the world by storm. From steam mechanization to power automation to data informatization, the Industry 4.0, driven by “intelligentization”, will completely subvert the expectations, changing perceptions of productivity and production relations in the traditional manufacturing industry by way of qualitative change – an immortal monument, perhaps,…
Additive & Conventional Manufacturing – Hybrid Manufacturing Techniques From C …
Croft Filters, based in Warrington, England, have been supplying custom filtration and separation solutions for over 31 years. Over this time, Croft has developed a reputation for their quality, bespoke service through manufacturing a variety of products for specific requirements. These products have included Filtration Cones, Baskets & Screens, Disc Filters and Filtration Housings amongst others, and they are made with Wire Mesh, Wedge Wire and Perforated Plate, depending on…
Digital Meter Market 2017 - Al-Jon Manufacturing, Environmental Manufacturing, H …
The Global Digital Meter Market 2017 Industry Research Report focused on global and regional market, major manufacturers, as well as the current state of the Digital Meter industry. First, "Global Digital Meter Industry 2017" report analyzed the basic scope of this industry like definition, specification, classification, application, industry policy, news analysis and Digital Meter industry chain structure.
Major Companies Covered in this report:-
Al-Jon Manufacturing
Heitman Laboratories
Kws Manufacturing Company
Kmb Systems
Obvius Holdingd Llc
Lubecorp Manufacturing
Quadlogic…
Competitive Segmentation of Global Mixed-mode Manufacturing Market 2016 Industry …
The market research report titled Mixed-mode Manufacturing Market Research Report 2016 provides a detailed overview of the global Mixed-mode Manufacturing market, in terms of crucial market factors such as the demand drivers, challenges, market segments, key companies, and the recent market trends. The quantitative and the qualitative information presented in this research study is based on primary and secondary sources of information. Moreover, much of the information contained in this…
